RANGER
"Rapid, robust & scaleable platform technology for fully automated reference laboratory grade Polymerase Chain Reaction (PCR) based diagnostics regardless of global setting"
| Coordinatore | ENIGMA DIAGNOSTICS LIMITED
Organization address
address: TETRICUS SCIENCE PARK PORTON DOWN Building 224 contact info |
| Nazionalità Coordinatore | United Kingdom [UK] |
| Totale costo | 4˙170˙658 € |
| EC contributo | 2˙982˙200 € |
| Programma | FP7-HEALTH
Specific Programme "Cooperation": Health |
| Code Call | FP7-HEALTH-2007-A |
| Funding Scheme | CP-TP |
| Anno di inizio | 2008 |
| Periodo (anno-mese-giorno) | 2008-07-01 - 2011-06-30 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
ENIGMA DIAGNOSTICS LIMITED
Organization address
address: TETRICUS SCIENCE PARK PORTON DOWN Building 224 contact info |
UK (SALISBURY) | coordinator | 0.00 |
| 2 |
BIOPHARMA TECHNOLOGY LTD
Organization address
address: WINNALL VALLEY ROAD 9 contact info |
UK (WINCHESTER) | participant | 0.00 |
| 3 |
BIOPLASTICS BV
Organization address
address: ROTSCHERWEG 61 contact info |
NL (LANDGRAAF) | participant | 0.00 |
| 4 |
BRUHN NEWTECH A/S
Organization address
address: GLADSAXEVEJ 402 contact info |
DK (SOEBORG) | participant | 0.00 |
| 5 |
HEALTH PROTECTION AGENCY HPA
Organization address
address: Central Office - 7th Floor, Holborn Gate - High Holborn 330 contact info |
UK (LONDON) | participant | 0.00 |
| 6 |
PERA INNOVATION LIMITED
Organization address
address: Innovation Park, Nottingham Road contact info |
UK (MELTON MOWBRAY, LEICESTERSHIRE) | participant | 0.00 |
| 7 |
QUEEN SIRIKIT NATIONAL INSTITUTE OF CHILD HEALTH
Organization address
address: "420/8 Rajavithi Road, Rajthevi" contact info |
TH (BANGKOK) | participant | 0.00 |
| 8 |
SAGENTIA GROUP LIMITED
Organization address
address: HARSTON MILL contact info |
UK (HARSTON CAMBRIDGE) | participant | 0.00 |
| 9 |
Tico Europe Limited
Organization address
address: SIDNEY STREET 80 contact info |
UK (FOLKESTONE) | participant | 0.00 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
'RANGER addresses the HEALTH-2007-2.3.3-4: Innovative point-of-care (POC) diagnostic tests for influenza call by providing a innovative solution to the immediate need for a rapid, robust, cost effective & user friendly POC diagnostic for influenza. We will develop the following real-time PCR system: 1) A robust, portable system allowing testing at the POC anywhere in the world 2) Raw sample to result automation of the entire test process including sample preparation 3) Parallel processing of multiple samples & different sample types (aspirates & swabs) in a modular, user-friendly system 4) RAPID & simple positive/negative result to the end user 5) No need for an external computer or laboratory equipment 6) Low cost consumable & reagents with a target cost of < €10 per test 7) Sample preparation & freeze dried reagents pre-packaged into an ambient stable consumable to eliminate cold storage chains 8) High confidence PCR results providing sensitivity & specificity equivalent to reference laboratory assays a. Suitable for the diagnosis of early stage infections where viral titres can be low b. Applicable to late surveillance & can be used to confirm the results from lower cost, low performance screen tests such as antibody assays that have low sensitivity and specificity. c. Simultaneous identification of specific influenza strains & viral subtypes using multiplexing real-time PCR assays will also allow exclusion of related respiratory diseases 9) Surveillance Management software & geographical data using GPS, allowing health authorities to manage early stage epidemics. The RANGER consortium includes WHO reference sites for human influenza diagnostics & world leading companies to develop and validate a POC influenza diagnostic system within 2 years. This system will allow health systems to be better prepared for epidemics by enabling early identification of infection and thus timely implementation of containment/treatment strategies.'